This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Avidus Announces Launch Of Asantae IS2™ Functional Beverage

Stocks in this article: AVD

VANCOUVER, BC and MESA, AZ, Oct. 17, 2013 /PRNewswire/ - Avidus Management Group Inc. (" Avidus" or the " Company") (TSX-V: AVD, OTC: ASNHF) through its wholly owned subsidiary Asantae is pleased to announce that IS2™, a proprietary new functional beverage is now shipping from all company warehouse locations.

Company President, Doug Ridley said, "Ninety days ago we promised a new Asantae and this week we delivered on those promises with the launch of this powerful functional beverage, a dynamic new website ( www.asantae.com), two new product videos, and a new business presentation video.  It's an exciting time at Asantae as we roll out all these improvements and enhancements.  We look forward to an even greater future ahead as the benefits accrue to the company."

According to MarketResearch.com, the functional beverage market had total revenues that exceeded $25 bn in 2012 and annual compounded growth rates of 6% per year for the trailing 5-years.   The market is projected to grow to over $38 bn by 2017.

Asantae's formulation team created IS2™ to support the body's natural immune system and inflammatory response.  These natural systems function best when they quickly and completely "Recognize, Respond, and Resolve" threats, invasions, infections and injuries in the body.  IS2™ is specifically formulated to help these systems function optimally.  Among many other ingredients to be discussed in more detailed news, IS2™ features Wellmune™, a powerful new compound with significant research behind it ( www.wellmune.com).

"Not only does IS2™ have tremendous health benefits, but it also will dramatically improve our overall gross margins," said Dan Lundell, CEO.  He further pointed out, "With comparable margins, IS2™ is an ideal companion to our groundbreaking weight-loss product RealW8™.  It has 300% better margins than two of our legacy products.  Beyond the obvious benefits of higher gross margins, enabling improved commissions drives recruiting growth and momentum."

Leading distributor Erik Cloud said, "As a full-time network marketing professional who has built my entire career around functional beverages, this is the  most functional health beverage I've ever seen.  I can build a massive organization in a relatively short time with a product that tastes this good, has benefits that people feel, and is easy for distributors like me to share.  The availability of this product at Asantae unleashes a new and powerful phase of recruiting, broadening the audience to other professional networkers who have achieved huge success with functional beverages; our timing could not be better."

About Avidus

Avidus Management Group Inc. (TSX-V: AVD, OTC: ASNHF) through its wholly owned subsidiary, Asantae, Inc. ( www.asantae.com) develops, produces and markets innovative nutritional products through direct and network marketing channels.  The ingredients in Asantae's products have been shown to reduce chronic low-grade inflammation and oxidative stress, and support a healthy immune system that, according to scientific and medical research, are the underlying conditions for most modern epidemic diseases (diabetes, heart disease, obesity, stroke, etc.). 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,805.41 +127.51 0.76%
S&P 500 1,964.58 +13.76 0.71%
NASDAQ 4,483.7150 +30.9230 0.69%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs